These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31727878)

  • 21. Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia.
    Jonas KG; Fochtmann LJ; Perlman G; Tian Y; Kane JM; Bromet EJ; Kotov R
    Am J Psychiatry; 2020 Apr; 177(4):327-334. PubMed ID: 32046533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of traumatic and violent victimization experiences in individuals with schizophrenia and schizoaffective disorder.
    Newman JM; Turnbull A; Berman BA; Rodrigues S; Serper MR
    J Nerv Ment Dis; 2010 Oct; 198(10):708-14. PubMed ID: 20921860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?
    Marsman A; Pries LK; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Kenis G; Lin BD; Luykx JJ; Rutten BPF; Guloksuz S; van Os J
    Schizophr Bull; 2020 Dec; 46(6):1353-1362. PubMed ID: 33259628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.
    Anderson-Schmidt H; Gade K; Malzahn D; Papiol S; Budde M; Heilbronner U; Reich-Erkelenz D; Adorjan K; Kalman JL; Senner F; Comes AL; Flatau L; Gryaznova A; Hake M; Reitt M; Schmauß M; Juckel G; Reimer J; Zimmermann J; Figge C; Reininghaus E; Anghelescu IG; Konrad C; Thiel A; von Hagen M; Koller M; Stierl S; Scherk H; Spitzer C; Folkerts H; Becker T; Dietrich DE; Andlauer TFM; Degenhardt F; Nöthen MM; Witt SH; Rietschel M; Wiltfang J; Falkai P; Schulze TG
    Schizophr Res; 2019 Aug; 210():255-261. PubMed ID: 30611655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.
    Dwyer DB; Kalman JL; Budde M; Kambeitz J; Ruef A; Antonucci LA; Kambeitz-Ilankovic L; Hasan A; Kondofersky I; Anderson-Schmidt H; Gade K; Reich-Erkelenz D; Adorjan K; Senner F; Schaupp S; Andlauer TFM; Comes AL; Schulte EC; Klöhn-Saghatolislam F; Gryaznova A; Hake M; Bartholdi K; Flatau-Nagel L; Reitt M; Quast S; Stegmaier S; Meyers M; Emons B; Haußleiter IS; Juckel G; Nieratschker V; Dannlowski U; Yoshida T; Schmauß M; Zimmermann J; Reimer J; Wiltfang J; Reininghaus E; Anghelescu IG; Arolt V; Baune BT; Konrad C; Thiel A; Fallgatter AJ; Figge C; von Hagen M; Koller M; Lang FU; Wigand ME; Becker T; Jäger M; Dietrich DE; Scherk H; Spitzer C; Folkerts H; Witt SH; Degenhardt F; Forstner AJ; Rietschel M; Nöthen MM; Mueller N; Papiol S; Heilbronner U; Falkai P; Schulze TG; Koutsouleris N
    JAMA Psychiatry; 2020 May; 77(5):523-533. PubMed ID: 32049274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.
    Creese B; Vassos E; Bergh S; Athanasiu L; Johar I; Rongve A; Medbøen IT; Vasconcelos Da Silva M; Aakhus E; Andersen F; Bettella F; Braekhus A; Djurovic S; Paroni G; Proitsi P; Saltvedt I; Seripa D; Stordal E; Fladby T; Aarsland D; Andreassen OA; Ballard C; Selbaek G;
    Transl Psychiatry; 2019 Oct; 9(1):273. PubMed ID: 31641104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does familiality predispose to both emergence and persistence of psychosis? A follow-up study.
    Verdoux H; van Os J; Sham P; Jones P; Gilvarry K; Murray R
    Br J Psychiatry; 1996 May; 168(5):620-6. PubMed ID: 8733802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide analysis of adolescent psychotic-like experiences shows genetic overlap with psychiatric disorders.
    Pain O; Dudbridge F; Cardno AG; Freeman D; Lu Y; Lundstrom S; Lichtenstein P; Ronald A
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):416-425. PubMed ID: 29603866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of polygenic risk scores for adults with psychosis.
    Landi I; Kaji DA; Cotter L; Van Vleck T; Belbin G; Preuss M; Loos RJF; Kenny E; Glicksberg BS; Beckmann ND; O'Reilly P; Schadt EE; Achtyes ED; Buckley PF; Lehrer D; Malaspina DP; McCarroll SA; Rapaport MH; Fanous AH; Pato MT; Pato CN; Bigdeli TB; Nadkarni GN; Charney AW
    Nat Med; 2021 Sep; 27(9):1576-1581. PubMed ID: 34489608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis.
    Warren TL; Tubbs JD; Lesh TA; Corona MB; Pakzad SS; Albuquerque MD; Singh P; Zarubin V; Morse SJ; Sham PC; Carter CS; Nord AS
    Mol Psychiatry; 2024 Aug; 29(8):2389-2398. PubMed ID: 38491343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward incorporating genetic risk scores into symptom networks of psychosis.
    Isvoranu AM; Guloksuz S; Epskamp S; van Os J; Borsboom D;
    Psychol Med; 2020 Mar; 50(4):636-643. PubMed ID: 30867074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis.
    Corsi-Zuelli F; Quattrone D; Ragazzi TCC; Loureiro CM; Shuhama R; Menezes PR; Louzada-Junior P; Del-Ben CM
    Psychol Med; 2024 Jul; 54(9):2099-2111. PubMed ID: 38414355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder.
    Markota M; Coombes BJ; Larrabee BR; McElroy SL; Bond DJ; Veldic M; Colby CL; Chauhan M; Cuellar-Barboza AB; Fuentes M; Kung S; Prieto ML; Rummans TA; Bobo WV; Frye MA; Biernacka JM
    Transl Psychiatry; 2018 Sep; 8(1):188. PubMed ID: 30201969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Musliner KL; Krebs MD; Albiñana C; Vilhjalmsson B; Agerbo E; Zandi PP; Hougaard DM; Nordentoft M; Børglum AD; Werge T; Mortensen PB; Østergaard SD
    Am J Psychiatry; 2020 Oct; 177(10):936-943. PubMed ID: 32660297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood maltreatment mediates the effect of the genetic background on psychosis risk in young adults.
    Marchi M; Elkrief L; Alkema A; van Gastel W; Schubart CD; van Eijk KR; Luykx JJ; Branje S; Mastrotheodoros S; Galeazzi GM; van Os J; Cecil CA; Conrod PJ; Boks MP
    Transl Psychiatry; 2022 Jun; 12(1):219. PubMed ID: 35650188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
    David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
    Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polygenic risk scores and the prediction of onset of mood and psychotic disorders in adolescents and young adults.
    Scott J; Crouse JJ; Medland S; Byrne E; Iorfino F; Mitchell B; Gillespie NA; Martin N; Wray N; Hickie IB
    Early Interv Psychiatry; 2024 Jun; 18(6):397-405. PubMed ID: 37787636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene × environment moderation and mediation.
    Elkrief L; Lin B; Marchi M; Afzali MH; Banaschewski T; Bokde ALW; Quinlan EB; Desrivières S; Flor H; Garavan H; Gowland P; Heinz A; Ittermann B; Martinot JL; Martinot MP; Nees F; Orfanos DP; Paus T; Poustka L; Hohmann S; Fröhner JH; Smolka MN; Walter H; Whelan R; Schumann G; Luykx J; Boks MP; Conrod PJ;
    Psychol Med; 2023 Apr; 53(5):1759-1769. PubMed ID: 37310336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.